Assessment of<i> </i>In-Situ Gelling Microemulsion Systems Upon Temperature and Dilution Condition for Corneal Delivery of Bevacizumab

Assessment of<i> </i>In-Situ Gelling Microemulsion Systems Upon Temperature and Dilution Condition for Corneal Delivery of Bevacizumab

Bevacizumab (BVZ), a recombinant humanized monoclonal antibody, has recently been proposed as a topical application in the treatment of anterior segment neovascularization; however, as there are some disadvantages in the administration of common eye-drops, ophthalmic topical drug delivery systems ar...

Full description

Bibliographic Details
Main Authors: Elena Peira, Giulia Chindamo, Daniela Chirio, Simona Sapino, Simonetta Oliaro-Bosso, Erica Rebba, Pavlo Ivanchenko, Marina Gallarate
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Pharmaceutics
Subjects:
microemulsions
in situ gelling systems
corneal delivery
intraocular neovascularization
Online Access:https://www.mdpi.com/1999-4923/13/2/258

Internet

https://www.mdpi.com/1999-4923/13/2/258

Similar Items